Abstract
The treatment and understanding of first-episode schizophrenia belongs to the greatest challenges in clinical psychiatry and psychiatric research. Antipsychotic drugs revolutionised the therapy of schizophrenia since their first introduction in the 1950s. However, there are still unsolved questions about an evidence-based and improved treatment of first-episode patients, which neurobiological and clinical studies can help answering.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.